An Ohio man wants at least $350,000 in punitive damages from General Electric Co. in a case over an injected contrast agent he claims caused an incurable, possibly fatal illness.
Abbott Laboratories has been hit with a putative collective action suit that alleges it misclassified sales representatives as exempt from a federal law mandating a premium pay rate for overtime hours, the latest in a series of suits against major drug companies alleging violations of state and federal overtime laws.
The states of Montana and Nevada have reached a settlement with Dey Inc., one of a slew of pharmaceutical companies involved in a massive antitrust class action alleging that the companies defrauded consumers by artificially inflating the prices of various prescription drugs.
AstraZeneca Pharmaceuticals filed a lawsuit against Teva Pharmaceutical Industries Ltd. in a New Jersey court Thursday over a patent for AstraZeneca's multibillion-dollar anti-psychotic drug Seroquel.
Former HealthSouth Corp. CEO Richard Scrushy, who was sentenced Thursday to six years and ten months' jail for bribing one-time Alabama governor Don Siegelman, has asked to be released pending an appeal.
Drug development and medical device company AsymmetRx Inc. filed suit against a group of rival diagnostic companies Wednesday, claiming they are infringing two of its patents describing certain antibodies used to diagnose prostate cancer.
A plaintiffs attorney and two former employees of the Hartford Insurance Co. have been indicted by a grand jury in connection with a scheme where the attorney allegedly gave the workers more than $3 million in kickbacks to settle silicosis claims.
Salt Lake City-based Idaho Technology Inc. sued rival biotech company Corbett Life Science Inc. on Wednesday, seeking to enforce its patent on a technique used in analyzing DNA.
After years of concern over the effects of antidepressants in pregnant women, two new studies have claimed that the risk of having children with birth defects is relatively low for women who stay on the drugs, adding fuel to the debate.
Biotechnology company StemCells Inc. has agreed to halt a patent suit brought against rival Neuralstem Inc. while the U.S. Patent and Trademark Office reevaluates the four patents-in-suit, the company said Thursday.
In a move that renews last year's debate over the merits of information technology expansion in health care, the Senate Health, Education, Labor and Pensions Committee passed the Wired for Health Care Quality bill on Thursday.
As plaintiffs’ attorneys prepare for their legal battle against Ortho-McNeil Pharmaceutical Co. and its controversial birth control patch, they are pushing for the Johnson & Johnson subsidiary to pull the patch off drug store shelves.
GlaxoSmithKline escalated its war over blockbuster antidepressant Paxil on another front Monday, filing suit against Mylan Laboratories Inc. in a New Jersey district court over the generics maker's alleged patent infringement.
Two health care technology companies at the center of a dispute over DNA patents have been given more time to negotiate a settlement after advising a federal court they were close to resolving their spat.
Drugs aimed at treating bone cancer and osteoporosis have suddenly become big business for plaintiffs attorneys, who continue to file suits against health care giants like Novartis Pharmaceutical Corp. alleging the medications have led to the painful deterioration of the jawbone.
Pfizer Inc. does not have to pay attorneys' fees to plaintiffs after it tried to remove the class action from state to federal court, an appeals court has ruled, overturning a district judge's award to a group of people who sued the drug maker for its marketing of anti-inflammatory painkillers Bextra and Celebrex.
The Supreme Court has agreed to hear a potentially landmark case that could clarify whether compliance with federal regulations shields companies from state product-liability laws, particularly in the realm of medical devices.
Drug maker AstraZeneca has asked a federal judge to dismiss the claims of 14 plaintiffs in the multidistrict product liability case filed over blockbuster anti-psychotic Seroquel, claiming the plaintiffs did not comply with a court order to provide the company with facts.
Australian biotechnology company Novogen Ltd. has notched another settlement with a health supplement maker in its enforcement of patents for plant-derived compounds used to treat menopause.
Concerned over being tried in the court of public opinion, Johnson & Johnson has urged a judge to keep confidential millions of documents that have been produced in connection with the multidistrict product liability litigation currently raging over popular birth control patch Ortho Evra.